scholarly journals Effect of Low-Dose Vitamin D Supplementation on Serum 25(OH)D in School Children and White-Collar Workers

Nutrients ◽  
2017 ◽  
Vol 9 (5) ◽  
pp. 505 ◽  
Author(s):  
Ronghua Zhang ◽  
Xiamusiye Muyiduli ◽  
Danting Su ◽  
Biao Zhou ◽  
Yueqiang Fang ◽  
...  
2020 ◽  
Vol 32 (5) ◽  
pp. 663-664
Author(s):  
Graziano Barera ◽  
Katia Maruca ◽  
Paola Sgaramella ◽  
Marina Di Stefano ◽  
Stefano Mora

2019 ◽  
Vol 54 (S1) ◽  
pp. 137-137
Author(s):  
H. Vafaei ◽  
N. Namazi ◽  
N. Asadi ◽  
M. Kasraeian ◽  
H. Raeisi Shahraki

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Amanda Zaleski ◽  
Gregory Panza ◽  
Heather Swales ◽  
Pankaj Arora ◽  
Christopher Newton-Cheh ◽  
...  

Introduction. Vitamin D deficiency is associated with the onset and progression of hypertension and cardiovascular disease (CVD). However, mechanisms underlying vitamin D deficiency-mediated increased risk of CVD remain unknown. We sought to examine the differential effect of high-dose versus low-dose vitamin D supplementation on markers of arterial stiffness among ~40 vitamin D deficient adults with prehypertension.Methods. Participants were randomized to high-dose (4000 IU/d) versus low-dose (400 IU/d) oral vitamin D3 for 6 months. 24 hr ambulatory blood pressure (BP), carotid-femoral pulse wave velocity, and pulse wave analyses were obtained at baseline and after 6 months of vitamin D supplementation.Results. There were no changes in resting BP or pulse wave velocity over 6 mo regardless of vitamin D dose (allp>0.202). High-dose vitamin D decreased augmentation index and pressure by 12.3 ± 5.3% (p=0.047) and 4.0 ± 1.5 mmHg (p=0.02), respectively. However, these decreases in arterial stiffness were not associated with increases in serum 25-hydroxyvitamin D over 6 mo (p=0.425).Conclusion. High-dose vitamin D supplementation appears to lower surrogate measures of arterial stiffness but not indices of central pulse wave velocity.Clinical Trial Registration. This trial is registered with www.clinicaltrials.gov (Unique Identifier:NCT01240512).


PLoS ONE ◽  
2017 ◽  
Vol 12 (5) ◽  
pp. e0175237 ◽  
Author(s):  
Davaasambuu Ganmaa ◽  
Jennifer J. Stuart ◽  
Nyamjav Sumberzul ◽  
Boldbaatar Ninjin ◽  
Edward Giovannucci ◽  
...  

2020 ◽  
Vol 52 (7S) ◽  
pp. 1093-1093
Author(s):  
Grace A. Zimmerman ◽  
Jeremy R. Townsend ◽  
Megan D. Jones ◽  
Jaclyn Morimune

2020 ◽  
Author(s):  
Atthakorn Jarusriwanna ◽  
Suchat Phusunti ◽  
Pojchong Chotiyarnwong ◽  
Aasis Unnanuntana

Abstract Background: Hypovitaminosis D can be observed in most fragility hip fracture patients. However, measurement of 25-hydroxyvitamin D [25(OH)D] level is costly and may not be available in some centers. Without the baseline 25(OH)D level, the appropriate dose of vitamin D supplementation is not known. The aim of this study was to evaluate the effectiveness and safety of vitamin D supplementation in fragility hip fracture patients compared between high- and low-dose vitamin D supplementation. Methods: A total of 140 patients diagnosed with fragility hip fracture were randomly allocated to either the high-dose (60,000 IU/week) or low-dose (20,000 IU/week) vitamin D2 supplementation group for 12 weeks. The number of patients who achieved optimal vitamin D level [25(OH)D level > 30 ng/mL], the proportion of patients who developed hypercalcemia, and the functional outcome were compared between groups. Results: Of the 140 patients who were enrolled, 21 patients were lost to follow-up during the study period. The remaining 119 patients (58 and 61 in the high- and low-dose group, respectively) were included in the final analysis. The high-dose group had a higher rate of serum 25(OH)D restoration to optimal level than the low-dose group (82.8% vs 52.5%, respectively; p <0.001). Approximately 3.4% and 1.6% of patients in the high- and low-dose groups, respectively, had mild hypercalcemia, but none developed moderate, severe, or symptomatic hypercalcemia. There were no differences in functional outcome scores between groups.Conclusions: In treatment settings where baseline serum 25(OH)D level can’t be evaluated, we recommend high-dose vitamin D2 of approximately 60,000 IU/week for 12 weeks, with subsequent switch to a maintenance dose. This regimen effectively restored serum vitamin D to an optimal level in 82.8% of patients without causing symptomatic hypercalcemia.Trial registration: The protocol of this study was retrospectively registered in the Thai Clinical Trials Registry database no. TCTR20180302007 on 20 February 2018.


Bone ◽  
2019 ◽  
Vol 122 ◽  
pp. 136-142 ◽  
Author(s):  
Homeira Vafaei ◽  
Nasrin Asadi ◽  
Maryam Kasraeian ◽  
Hadi Raeisi Shahraki ◽  
Khadije Bazrafshan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document